Physicochemical interactions with (-)-epigallocatechin-3-gallate drive structural modification of celiac-associated peptide α 2 -gliadin (57-89) at physiological conditions

(-)-Epigallocatechin-3-gallate (EGCG), a major phenolic constituent of tea, has been shown to have biological activity within inflammatory pathways involved with food allergies and intolerances. Proposed mechanisms for this effect include sequestration and structural modification of immunostimulator...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Food & function 2019-05, Vol.10 (5), p.2997-3007
Hauptverfasser: Van Buiten, Charlene B, Yennawar, Neela H, Pacheco, Carlos N, Hatzakis, Emmanuel, Elias, Ryan J
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3007
container_issue 5
container_start_page 2997
container_title Food & function
container_volume 10
creator Van Buiten, Charlene B
Yennawar, Neela H
Pacheco, Carlos N
Hatzakis, Emmanuel
Elias, Ryan J
description (-)-Epigallocatechin-3-gallate (EGCG), a major phenolic constituent of tea, has been shown to have biological activity within inflammatory pathways involved with food allergies and intolerances. Proposed mechanisms for this effect include sequestration and structural modification of immunostimulatory proteins as a result of interactions with EGCG. The present study employs biophysical techniques including dynamic light scattering, circular dichroism and nuclear magnetic resonance to elucidate the likely mechanism(s) by which EGCG interacts with α2-gliadin (57-89) (α2g), an immunodominant peptide in celiac disease pathogenesis. We demonstrate that EGCG interacts with α2g in a multi-phase reaction driven by non-specific binding, resulting in the formation of polydisperse EGCG/α2g complexes which induce changes in peptide structure. We also show that these interactions occur at a range of pH levels associated with digestion, including pH 2.0, 6.8 and 7.5. Based on previous reports of binding specificity of enzymes and antigen presenting cells in celiac disease pathogenesis, our results provide foundational support for EGCG to prevent recognition of immunostimulatory gliadin epitopes by the body and thus prevent the inflammatory and autoimmune response associated with celiac disease.
doi_str_mv 10.1039/c9fo00553f
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1039_C9FO00553F</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>31086895</sourcerecordid><originalsourceid>FETCH-LOGICAL-c995-75e9f00ddf68641603c596943acc920f8bfe4d1503fffe24e843e6b24ef8c7413</originalsourceid><addsrcrecordid>eNo9UEFOwzAQtBCIVqUXHoB8bJEMThyn9hFVFJAqlUMP3CJ3bTdGSRzFKaiP4sBHeBNJS9nLzmhnR6NB6DqidxFl8h6k9ZRyzuwZGsY0iUnK6dv5CScyHaBxCO-0GyalkOISDVhERSokH6Kv13wfHHjITelAFdhVrWkUtM5XAX-6NscTMiWmdltVFB5UayB3FWGk5x3DunEfBoe22UG7azqH0mtnO6_eAnuLwRROAVEheHDdh8a1qVunDf75xjEm2-6sXYUnfEaEnGLV4roP5Qu_PUQCX2l3CHSFLqwqghn_7RFaLx7X82eyXD29zB-WBKTkZMaNtJRqbVORJlFKGXCZyoQpABlTKzbWJDrilFlrTZwYkTCTbjpgBcySiI3Q7dEWGh9CY2xWN65UzT6LaNa3ns3lYnVofdGJb47iercpjf6XnjpmvyFkgK4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Physicochemical interactions with (-)-epigallocatechin-3-gallate drive structural modification of celiac-associated peptide α 2 -gliadin (57-89) at physiological conditions</title><source>Royal Society Of Chemistry Journals 2008-</source><creator>Van Buiten, Charlene B ; Yennawar, Neela H ; Pacheco, Carlos N ; Hatzakis, Emmanuel ; Elias, Ryan J</creator><creatorcontrib>Van Buiten, Charlene B ; Yennawar, Neela H ; Pacheco, Carlos N ; Hatzakis, Emmanuel ; Elias, Ryan J</creatorcontrib><description>(-)-Epigallocatechin-3-gallate (EGCG), a major phenolic constituent of tea, has been shown to have biological activity within inflammatory pathways involved with food allergies and intolerances. Proposed mechanisms for this effect include sequestration and structural modification of immunostimulatory proteins as a result of interactions with EGCG. The present study employs biophysical techniques including dynamic light scattering, circular dichroism and nuclear magnetic resonance to elucidate the likely mechanism(s) by which EGCG interacts with α2-gliadin (57-89) (α2g), an immunodominant peptide in celiac disease pathogenesis. We demonstrate that EGCG interacts with α2g in a multi-phase reaction driven by non-specific binding, resulting in the formation of polydisperse EGCG/α2g complexes which induce changes in peptide structure. We also show that these interactions occur at a range of pH levels associated with digestion, including pH 2.0, 6.8 and 7.5. Based on previous reports of binding specificity of enzymes and antigen presenting cells in celiac disease pathogenesis, our results provide foundational support for EGCG to prevent recognition of immunostimulatory gliadin epitopes by the body and thus prevent the inflammatory and autoimmune response associated with celiac disease.</description><identifier>ISSN: 2042-6496</identifier><identifier>EISSN: 2042-650X</identifier><identifier>DOI: 10.1039/c9fo00553f</identifier><identifier>PMID: 31086895</identifier><language>eng</language><publisher>England</publisher><ispartof>Food &amp; function, 2019-05, Vol.10 (5), p.2997-3007</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c995-75e9f00ddf68641603c596943acc920f8bfe4d1503fffe24e843e6b24ef8c7413</citedby><cites>FETCH-LOGICAL-c995-75e9f00ddf68641603c596943acc920f8bfe4d1503fffe24e843e6b24ef8c7413</cites><orcidid>0000-0001-9613-9100 ; 0000-0001-8416-8772 ; 0000-0002-5607-5517 ; 0000-0003-3946-0787 ; 0000-0001-7278-659X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31086895$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Van Buiten, Charlene B</creatorcontrib><creatorcontrib>Yennawar, Neela H</creatorcontrib><creatorcontrib>Pacheco, Carlos N</creatorcontrib><creatorcontrib>Hatzakis, Emmanuel</creatorcontrib><creatorcontrib>Elias, Ryan J</creatorcontrib><title>Physicochemical interactions with (-)-epigallocatechin-3-gallate drive structural modification of celiac-associated peptide α 2 -gliadin (57-89) at physiological conditions</title><title>Food &amp; function</title><addtitle>Food Funct</addtitle><description>(-)-Epigallocatechin-3-gallate (EGCG), a major phenolic constituent of tea, has been shown to have biological activity within inflammatory pathways involved with food allergies and intolerances. Proposed mechanisms for this effect include sequestration and structural modification of immunostimulatory proteins as a result of interactions with EGCG. The present study employs biophysical techniques including dynamic light scattering, circular dichroism and nuclear magnetic resonance to elucidate the likely mechanism(s) by which EGCG interacts with α2-gliadin (57-89) (α2g), an immunodominant peptide in celiac disease pathogenesis. We demonstrate that EGCG interacts with α2g in a multi-phase reaction driven by non-specific binding, resulting in the formation of polydisperse EGCG/α2g complexes which induce changes in peptide structure. We also show that these interactions occur at a range of pH levels associated with digestion, including pH 2.0, 6.8 and 7.5. Based on previous reports of binding specificity of enzymes and antigen presenting cells in celiac disease pathogenesis, our results provide foundational support for EGCG to prevent recognition of immunostimulatory gliadin epitopes by the body and thus prevent the inflammatory and autoimmune response associated with celiac disease.</description><issn>2042-6496</issn><issn>2042-650X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNo9UEFOwzAQtBCIVqUXHoB8bJEMThyn9hFVFJAqlUMP3CJ3bTdGSRzFKaiP4sBHeBNJS9nLzmhnR6NB6DqidxFl8h6k9ZRyzuwZGsY0iUnK6dv5CScyHaBxCO-0GyalkOISDVhERSokH6Kv13wfHHjITelAFdhVrWkUtM5XAX-6NscTMiWmdltVFB5UayB3FWGk5x3DunEfBoe22UG7azqH0mtnO6_eAnuLwRROAVEheHDdh8a1qVunDf75xjEm2-6sXYUnfEaEnGLV4roP5Qu_PUQCX2l3CHSFLqwqghn_7RFaLx7X82eyXD29zB-WBKTkZMaNtJRqbVORJlFKGXCZyoQpABlTKzbWJDrilFlrTZwYkTCTbjpgBcySiI3Q7dEWGh9CY2xWN65UzT6LaNa3ns3lYnVofdGJb47iercpjf6XnjpmvyFkgK4</recordid><startdate>20190522</startdate><enddate>20190522</enddate><creator>Van Buiten, Charlene B</creator><creator>Yennawar, Neela H</creator><creator>Pacheco, Carlos N</creator><creator>Hatzakis, Emmanuel</creator><creator>Elias, Ryan J</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0001-9613-9100</orcidid><orcidid>https://orcid.org/0000-0001-8416-8772</orcidid><orcidid>https://orcid.org/0000-0002-5607-5517</orcidid><orcidid>https://orcid.org/0000-0003-3946-0787</orcidid><orcidid>https://orcid.org/0000-0001-7278-659X</orcidid></search><sort><creationdate>20190522</creationdate><title>Physicochemical interactions with (-)-epigallocatechin-3-gallate drive structural modification of celiac-associated peptide α 2 -gliadin (57-89) at physiological conditions</title><author>Van Buiten, Charlene B ; Yennawar, Neela H ; Pacheco, Carlos N ; Hatzakis, Emmanuel ; Elias, Ryan J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c995-75e9f00ddf68641603c596943acc920f8bfe4d1503fffe24e843e6b24ef8c7413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Van Buiten, Charlene B</creatorcontrib><creatorcontrib>Yennawar, Neela H</creatorcontrib><creatorcontrib>Pacheco, Carlos N</creatorcontrib><creatorcontrib>Hatzakis, Emmanuel</creatorcontrib><creatorcontrib>Elias, Ryan J</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Food &amp; function</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Van Buiten, Charlene B</au><au>Yennawar, Neela H</au><au>Pacheco, Carlos N</au><au>Hatzakis, Emmanuel</au><au>Elias, Ryan J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Physicochemical interactions with (-)-epigallocatechin-3-gallate drive structural modification of celiac-associated peptide α 2 -gliadin (57-89) at physiological conditions</atitle><jtitle>Food &amp; function</jtitle><addtitle>Food Funct</addtitle><date>2019-05-22</date><risdate>2019</risdate><volume>10</volume><issue>5</issue><spage>2997</spage><epage>3007</epage><pages>2997-3007</pages><issn>2042-6496</issn><eissn>2042-650X</eissn><abstract>(-)-Epigallocatechin-3-gallate (EGCG), a major phenolic constituent of tea, has been shown to have biological activity within inflammatory pathways involved with food allergies and intolerances. Proposed mechanisms for this effect include sequestration and structural modification of immunostimulatory proteins as a result of interactions with EGCG. The present study employs biophysical techniques including dynamic light scattering, circular dichroism and nuclear magnetic resonance to elucidate the likely mechanism(s) by which EGCG interacts with α2-gliadin (57-89) (α2g), an immunodominant peptide in celiac disease pathogenesis. We demonstrate that EGCG interacts with α2g in a multi-phase reaction driven by non-specific binding, resulting in the formation of polydisperse EGCG/α2g complexes which induce changes in peptide structure. We also show that these interactions occur at a range of pH levels associated with digestion, including pH 2.0, 6.8 and 7.5. Based on previous reports of binding specificity of enzymes and antigen presenting cells in celiac disease pathogenesis, our results provide foundational support for EGCG to prevent recognition of immunostimulatory gliadin epitopes by the body and thus prevent the inflammatory and autoimmune response associated with celiac disease.</abstract><cop>England</cop><pmid>31086895</pmid><doi>10.1039/c9fo00553f</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-9613-9100</orcidid><orcidid>https://orcid.org/0000-0001-8416-8772</orcidid><orcidid>https://orcid.org/0000-0002-5607-5517</orcidid><orcidid>https://orcid.org/0000-0003-3946-0787</orcidid><orcidid>https://orcid.org/0000-0001-7278-659X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 2042-6496
ispartof Food & function, 2019-05, Vol.10 (5), p.2997-3007
issn 2042-6496
2042-650X
language eng
recordid cdi_crossref_primary_10_1039_C9FO00553F
source Royal Society Of Chemistry Journals 2008-
title Physicochemical interactions with (-)-epigallocatechin-3-gallate drive structural modification of celiac-associated peptide α 2 -gliadin (57-89) at physiological conditions
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T16%3A48%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Physicochemical%20interactions%20with%20(-)-epigallocatechin-3-gallate%20drive%20structural%20modification%20of%20celiac-associated%20peptide%20%CE%B1%202%20-gliadin%20(57-89)%20at%20physiological%20conditions&rft.jtitle=Food%20&%20function&rft.au=Van%20Buiten,%20Charlene%20B&rft.date=2019-05-22&rft.volume=10&rft.issue=5&rft.spage=2997&rft.epage=3007&rft.pages=2997-3007&rft.issn=2042-6496&rft.eissn=2042-650X&rft_id=info:doi/10.1039/c9fo00553f&rft_dat=%3Cpubmed_cross%3E31086895%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/31086895&rfr_iscdi=true